10.1186/s12986-017-0217-z Summary Keywords GLP-1, incretin mimetics, neurodegeneration, Parkinsons disease, phytoconstituents, sirtuins, -synuclein Citation Juthi SS, Ansari P, Ahmed MF, Khan JT, Seidel V, Kumar S, Kumari R, McKillop A, Abdel-Wahab YHA and Flatt PR (2026) Molecular mechanisms underlying Parkinsons disease and role of phytochemicals, -synuclein, sirtuins, and incretin mimetics in potential therapy
Its a gentler approach than pushing your body into a cascade of artificial hormones
Pending finalization, the April 30 proposal represents FDAs stated policy position rather than enforceable rule
Both compounds have demonstrated significant biological activity in experimental models and have begun to attract attention from healthcare professionals seeking novel therapeutic modalities